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Experiments were carried out in the hamster to compare the relative susceptibility of Necator americanus and 
Ancylostoma ceylunicum to treatment with ivermectin. A.ceylanicum was found to be 300 times more 
sensitive to the anthelmintic with a 50% effective dose (ED,,) of the order of lo-15pg kg-’ body weight 
whilst that for N.americanus approximated to 3-5 mg kg-‘. Furthermore, whereas complete clearance of 
A.ceylunicum was observed with a dose of lOOfig kg- ‘, Namericunus was not totally removed after treatment 
with 25 mg kg-‘, the highest dose tested. Both parasites proved equally sensitive to pyrantel with an ED,, of 
1-12 mg kg-’ for A.ceylanicum and 5-25 mg kg-’ for N.americanus. Treatment with pyrantel at 1OOmg kg-’ 
completely eliminated worms of both species and doses of 25-50 mg kg-’ were > 90% effective. In addition 
to worm burdens, changes in host weight and PCV were also recorded and it was shown that both 
parameters could be used to evaluate the success/failure of treatment. 
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INTRODUCTION 
THE introduction of ivermectin, in 1981 as an 
antiparasitic drug for helminths and arthropods has 
had a marked impact on the treatment of animal 
diseases and recently, following successful trials in 
humans, a licence has been granted for treatment of 
patients with onchocerciasis (Campbell, 1985; Green, 
Brown & Taylor, 1989). Many of the common gastro- 
intestinal nematodes are highly susceptible to 
ivermectin, at concentrations measured in pg kg-’ 
body weight, considerably smaller than the mg kg-’ 
concentrations required for effective antiparasite 
activity of other anthelmintics. However, some 
parasites have proved to be exceptionally resistant to 
ivermectin, (Heligmosomoides polygyrus, Trichuris 
trichiura and hookworms; Wahid, Behnke & Conway, 
1989; Whitworth, Morgan, Maude, McNicholas & 
Taylor, 1991). 
Several field studies have shown that ivermectin, at 
the doses suitable for treatment of humans, has little 
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impact on hookworm infection (Whitworth et al., 
1991; Richard-Lenoble, Kombila, Rupp, Pappayliou, 
Gaxotte, Nguiri & Aziz, 1988). However, these 
observations contrast with the results of studies in 
animals which have indicated that Ancylostoma spp. 
are susceptible (Egerton, Eary & Suhayda, 1985). 
Field data is mostly based on Necator americanus, a 
human hookworm which has no close relative among 
laboratory-maintained animal parasites and which 
itself cannot be easily maintained in dogs, the hosts 
generally used for chemotherapeutic studies of 
hookworm infection (Behnke, 1990). The implied 
difference in relative susceptibility to ivermectin of 
hookworm species from the genera Ancylostoma and 
Necator therefore requires urgent evaluation. In this 
paper we describe experiments in which we compared 
the relative susceptibility to ivermectin of Ancyfostoma 
ceylanicum and N.americanus in hamsters, a host in 
which both species develop to patent infection. Our 
results establish that there is indeed a profound 
difference in susceptibility to ivermectin. 
MATERIALS AND METHODS 
Parasites and hosts. Infective larvae of N.americanus were 
obtained in 1983 from Dr Rajasekariah of CIBA-GEIGY 
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TABLE I.-EXPERIMENTALDESIGN 
Experiment No. of Parasite* No. of larvae Anthelmintict Day of Interval to 
hamsters/ administered infection autopsy 
group when treated (days) 
1 3 A.ceylanicum 50 Ivermcctin 18 3 
2 3 A.ceylanicum 100 Ivermectin 21 3 
3 4-5 A.ceylanicum 70 Ivermectin 22 6 
4 3 N.americanus 108 Ivermectin 35 3 
5 3 N.americanus 144 Ivermectin 35 3 
6 4-5 N.americanus 100 Ivermectin 28 8 
7 3 A.ceylanicum 100 Pyrantel 21 3 
8 446 Aceylanicum 50 Pyrantel 21 7 
9 4-5 A.ceylanicum 66 Pyrantel 22 6 
10 3 N.americanus 108 Pyrantel 35 3 
11 3 N.americanus 160 Pyrantel 35 3 
12 3 N.americanus 70 Pyrantel 30 7 
*Ancylostoma ceylanicum larvae were administered orally to mature hamsters. Necator americanus larvae were 
given percutaneously to neonatal (2-3-day-old) hamsters. 
tIvermectin was administered subcutaneously. Pyrantel was given orally. 
Hindustan Ltd., Bombay, India and the parasite has been 
maintained since by regular passage through hamsters as 
described originally by Sen (1972) and Behnke, Wells & 
Brown (1986). It is important to note here that N.americanus 
will only mature to patency following exposure of neonatal 
(I-3-day-old) hamsters to infection (Rajasekariah, Deb, 
Dhage & Bose, 1985). Experiments with N.americanus were 
therefore limited by the need for synchronized mating of 
female hamsters and by resulting litter sizes. Aceylanicum 
was also obtained from Dr Rajasekariah and was passaged 
through adult hamsters using techniques which have been 
described by Garside & Behnke (1989). All the animals used 
in this work were syngeneic DSN hamsters originally 
purchased from Intersimian Ltd, Oxford, U.K., but now 
maintained, under conventional conditions with access to 
food and water ad libitum, as a closed breeding colony in the 
Department of Life Science at Nottingham University. Both 
sexes were used but all the animals in any one experiment 
were of the same sex. Experimental groups were set up in 
separate cages at least l-2 weeks before infection. In some 
experiments all individuals were weighed a week before 
infection, on the day of infection and treatment and on the 
day of autopsy. Fifty ~1 blood samples were obtained in 
heparinized capillary tubes, under trilene anaesthesia for 
measurement of the packed cell volume (PCV) at times 
stated. 
Anthelmintic treatment. Ivermectin was available as a 
commercial preparation, Ivomec which contains 1% w/v of 
the anthelmintic (Merck Sharp & Dohme AGVET). The 
required concentrations of ivermectin were obtained by 
appropriate dilution of this preparation with sterile distilled 
water. The resulting fine suspension was injected sub- 
cutaneously in volumes of 0.05-0.4 ml within minutes of 
preparation. Pyrantel embonate (Strongid-P paste, Pfizer) 
was administered orally to hamsters after appropriate dilu- 
tion of the stock with sterile distilled water. 
Statistical analysis of results. The results are presented as 
group mean values (MWR) f standard error (WM.). Non- 
parametric statistical procedures were used to analyse the 
data sets, because small sample sizes precluded the assump- 
tion of normal distribution (Sokal & Rohlf, 1969). When 
more than 2 groups required comparison at a single time 
point the Kruskal-Wallis statistic H was calculated to 
determine whether there was a significant treatment effect. If 
significant, specific groups were compared to the control 
group (or as stated) by the Mann-Whitney U-test. Cor- 
relations between variables were tested by the Spearman 
Rank Order Correlation Test and the statistic Y, is given, as 
appropriate. Probabilities were calculated from statistics 
tables and are presented as follows: * P = 0.05; ** 0.05 > P 
> 0.02; *** 0.02 > P 2 0.01; **** 0.01 > P 2 0.001; ***** 
P < 0.001. 
RESULTS 
Effect of ivermectin on A.ceylanicum 
In a preliminary experiment (Experiment 1) 5 
groups of hamsters, each of 3 animals, were treated 
either with 20, 5, 1.25 or 0.31 mg kg-’ body weight of 
ivermectin subcutaneously 18 days after exposure to 
50 L3. One group was left untreated. When killed 3 
days after treatment worms were recovered only from 
the control untreated animals (20.3 + 4.6). 
Two further experiments were then carried out to 
establish the cut-off point for drug efficacy and to 
obtain data for 50% effective dose (ED,,) and com- 
plete clearance of worms. The experimental design of 
this (and all other experiments) is given in Table 1 and 
the results are illustrated in Fig. l(A). A. ceylanicum 
proved to be sensitive to ivermectin with a significant 
reduction in worm burden being achieved with doses 
of IO-100 pg kg-’ body weight. However, complete 
clearance of worms required 100-500 pg kg-’ body 
weight. 
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FIG. 1. Ancylostoma ceylanicum and Necator americanus 
adult worm burdens in hamsters treated with various doses of 
ivermectin. For details of the experimental designs ee Table 
I. Statistical analysis: Groups were compared to the 
untreated control group in each case. * P = 0.05; 2’ 0.05 > 
P 2 0.025; 3* 0.025 > P 2 0.01; 4’ 0.01 > P 2 0.001. 
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FIG. 2. Comparison of the efficacy of ivermectin against 
Ancylostoma ceylanicum and Necator americanus. Solid 
symbols represent experiments with A.ceylanicum and open 
symbols N.americanus. 
Effect of ivermectin on N.americanus 
Three experiments were carried out to determine the 
efficacy of ivermectin against N.umericanus (Experi- 
ments 4-6). The doses investigated are given in Fig. 
l(B). In Experiment 4 no significant reduction in worm 
burden was obtained when doses ranging from 39 pg 
to 1.25 mg kg-’ were examined. In Experiment 55 mg 
kg-’ resulted in a 5 1.6% reduction in worm burden but 
because of small group size and variation in worm 
establishment his was not a significant reduction. 
However, 10 mg kg-‘, gave 92.6% clearance ofworms 
(P = 0.05). In Experiment 6, a dose of 5 mg kg-’ gave 
59.4% protection (P = 0.008) and a significant effect 
was also detected with 2.5 mg kg-’ (33.4% reduction, 
P < 0.032) but complete clearance of worms was not 
achieved even with a dose of 25 mg kg-’ (98.4% 
reduction in worm burden). The results therefore show 
that N.americanus is not affected by doses lower than 
2.5 mg kg-’ and that complete clearance of worms 
requires doses in excess of 25 mg kg-‘. 
Comparison of the effect of ivermectin on A. ceylanicum 
and N.americanus 
Figure 2 summarizes the data from 5 experiments. 
Experiment 4 was omitted because none of the doses 
examined were effective against N.americanus. It can 
be seen that ED, for A.ceyZanicum is of the order of 
l&15 pg kg-’ whilst that of N.americanus approx- 
imates to 3-5 mg kg-‘. On the basis of these results 
A.ceyZanicum is approximately 300 times more 
sensitive to ivermectin than N.americanus. Likewise, 
whereas complete clearance of A.ceyfanicum was 
observed with a dose of 100 pg kg-‘, N.americanus was 
not totally removed after treatment with 25 mg kg-‘, 
the highest dose tested. 
Comparison of the effect of pyrantel on A.ceylanicum 
and N.americanus 
The difference in sensitivity to ivermectin between 
these 2 hookworm species prompted us to compare 
sensitivity to pyrantel, an anthelmintic known to have 
comparable fficacy against worms of both genera. We 
were particularly concerned that our results with 
ivermectin might reflect an artifact of the system rather 
than an intrinsic difference in drug sensitivity. There- 
fore, 6 further experiments were carried out in which 
hamsters were infected with either A.ceyZunicum or 
N.americanus and were treated with various doses of 
pyrantel. 
The results of 5 experiments are summarized in Figs. 
3 and 4. Experiment 10, which is not illustrated, 
comprised 5 groups of 3 hamsters each exposed to 164 
L3 of N.americanus. Four of the groups were dosed 35 
days p.i. with either 1, 2.5, 5.0 or 10 mg kg-’ of 
pyrantel. The recovery of worms from the control 
group on this occasion was more variable than normal 
(49.3 f 25.4) and there was no evidence of an effect at 
5 mg kg-’ (57.0 f 23.52) but the group treated with 10 
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FIG. 3. Ancylostoma ceylanicum and Necator americanus 
adult worm burdens in hamsters treated with various doses of 
pyrantel. For details of the experimental designs ee Table 1. 
Statistical analysis: Groups were compared to the untreated 
control group in each case. * P = 0.05; 3* 0.025 > P 2 0.01; 
4* 0.01 1 P 2 0.001. 
mg kg-’ had a 50% reduction relative to the control 
group (24.67 f 11.3). This result was broadly con- 
firmed in Experiment 11 in which 6.1 mg kg-’ gave 
67.9% protection (Fig. 3B). However, in Experiment 
12 N.americanus appeared to be less sensitive with 10 
mg kg-’ giving only a 11.3% reduction relative to 
controls and 25 mg kg-’ 46.1% (Fig. 3B). The animals 
in Experiment 12 harboured heavier worm burdens 
than those in Experiment 11 and this may have been a 
factor affecting overall drug efficacy. 
The sensitivity of A.ceylunicum to pyrantel was 
similar to that of N.americunus (Fig. 3A). Again, there 
was some variation between the experiments but LD,, 
approximated to l-12 mg kg-’ for A.ceylunicum and 
5-25 mg kg-’ for N.umericunus (Fig. 4). The lowest 
dose of pyrantel giving complete elimination of A. 
ceylunicum was 25 mg kg-’ in Experiment 7, but the 
same dose left a few worms in Experiments 8 and 9 
(98.9 and 97.8% protection, respectively). Fifty mg 
kg-’ completely cleared worms in Experiment 9 but 
Dose of pyrantel (m&kg body weight) 
FIG. 4. Comparison of the efficacy of pyrantel against 
Ancylostoma ceylanicum and Necator americanus. Solid 
symbols represent experiments with A.ceylanicum and open 
symbols N.americanus. 
left some adult worms in Experiment 8 (98.9% 
protection). Therefore, the minimum dose which 
guaranteed complete removal of all adult worms was 
established as 100 mg kg-‘. This pattern was similar 
for N.umericunus with 25 mg kg-’ giving 98.3% 
protection in Experiment 11 but only 46.1% in 
Experiment 12. We tested 100 mg kg-’ on one occasion 
against N.umericunus and the result was 100% clear- 
ance of all worms (Fig. 3B, Experiment 11). 
Comparison of the effect of both unthelmintics on 
changes in weight and PCV of hamsters infected with 
A.ceylanicum and N.americanus 
In addition to recording changes in worm burden 
following treatment we also monitored changes in 
PCV (Fig. 5) and body weight (not illustrated) in some 
experiments. Normal PCV values in adult hamsters 
average about 52% with a range from 50 to 55% (Fig. 
5C). In Experiments 3 and 9, in which adult hamsters 
were infected with A.ceylunicum, PCV dropped uni- 
formly to just below 30% (Experiment 3) or just above 
30% (Experiment 9) in all groups by 7 or 6 days pi., 
respectively. The difference in magnitude of the 
reduction of the PCVs was a reflection of the heavier 
mean worm burden in Experiment 3 (Fig. lA, MWR 
= 52 f 7.1) relative to that of Experiment 9 (Fig. 3A, 
MWR = 36.4 f 3.3). Following treatment with either 
ivermectin or pyrantel at doses which did not reduce 
the worm burden, PCV remained depressed. However, 
all groups in which treatment resulted in worm loss, 
had improved PCV with restoration closest to normal 
levels in those groups which showed more than 90% 
reduction in worm burdens. Worm loss was closely 
paralleled by increase in PCV (Experiment 3, r, = 
0.82, P = 0.024; Experiment 9, rS = 0.922, P = 0.001) 
over the period between treatment and autopsy for 
worm counts. 
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FIG. 5. Relationship between changes inPCV in the period between treatment and 
autopsy, and protection (% of worm burden lost) as a result of treatment. 
The data for changes in weight were less clear-cut, 
but nevertheless support similar conclusions to those 
linking worm counts and changes in PCV. In Experi- 
ment 3 the mean weight of the untreated control group 
was less on the day of autopsy than on the day of 
treatment (97.4 rt. 23.7, 104.4 f 16.4, respectively) 
and similar losses of weight were detected in animals 
given 5 or 10 pg kg-’ of ivermectin in which there was 
no loss of worms following treatment. All the groups 
treated with ivermectin at more than 25 pg kg-’ had 
higher means, indicating that there was some weight 
gain (e.g. hamsters given 100 pg kg-’ weighed 104.5 f
4.4 g on the day of treatment and 110.2 f 5.1 g, 7 days 
later at autopsy), but there were no significant dif- 
ferences between the groups. In Experiment 9, where 
the number of worms establishing was lower than in 
Experiment 3, all groups (except animals treated with 
5 mg kg-’ which lost 2 gm) continued to increase in 
weight between the day of treatment with pyrantel and 
autopsy. The mean weight gain in groups given 
pyrantel at 10 mg kg-’ or more ranged from 6.1 to 11.2 
g. In contrast those groups receiving less than 10 mg 
kg-’ showed a maximum mean weight gain of 4.25 g. 
Thus, there was some indication that animals in which 
the worm burden was effectively reduced gained 
weight faster than those in which the parasites per- 
sisted. 
In experiments with N.americanus the interval be- 
tween infection and autopsy was longer because 
N.americanus moult to the preadult stage 21-23 days 
pi. and do not become patent until after 4 weeks of 
infection. The effect of N.americanus on the PCV was 
more severe in Experiments 6 and 12 than that of 
Axeylanicum in Experiments 3 and 9 and, as can be 
seen from Figs. 5(B) and (D), PCVs continued to 
decline in animals which were not treated and in those 
given doses of anthelmintic which failed to make a 
significant impact on the worm burdens. In 
Experiment 6 hamsters given more than 5 mg kg-’ of 
ivermectin (Fig. 5B) either stabilized their PCV or 
showed an increase over the interval between treat- 
ment and autopsy. There was a significant relationship 
between the change in PCV and loss of worms 
following treatment with anthelmintic (rr = 0.886, P 
= 0.019). However, in Experiment 12 where a shorter 
interval separated treatment and assessment ofPCV (5 
days) this relationship was not significant (r, = 0.667). 
Changes in weight in Experiments 6 and 12 closely 
paralleled anthelmintic efficacy. Thus in Experiment 6 
hamsters given 2.5 mg kg-! of ivermectin or less, lost 
weight between treatment and autopsy, while those 
given more gained weight. There was an exception in 
the group given 10 mg kg-‘, but this group also 
showed a smaller reduction in worms than animals 
given only 5 mg kg-‘. Overall there was a perfect 
correlation between the change in weight and loss of 
worms following treatment (I, = 1, P < 0.001). In 
Experiment 12, only hamsters given 2.5 mg kg-’ of 
pyrantel or untreated lost weight between treatment 
and autopsy (e.g. the mean weight of untreated 
controls was 42.8 + 2.7 g on the day of treatment and 
42.4 f 6.8 g at autopsy). All groups given 5 mg kg-‘, 
or more, gained weight (e.g. mean weight of hamsters 
given 50 mg kg-’ was 45.3 f 13.8 and 57.4 f 16.9 at 
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treatment and autopsy, respectively). Again there was 
a significant relationship between the mean change in 
weight over the period from treatment o autopsy and 
loss of worms (r, = 0.928, P = 0.008). 
DISCUSSION 
The results reported in this paper provide the first 
direct comparison of hookworm species from the two 
important genera AncyIostoma and Necator for their 
sensitivity to ivermectin. Ancylostoma is 300 times 
more sensitive than Necator to treatment with this 
anthelmintic. The relative insensitivity of 
N.americanus to ivermectin in the hamster model has 
been reported previously by Rajasekariah, Deb, 
Dhage & Bose (1989) with a ED, of 8.32 mg kg-’ 
(marginally higher than our estimate of 3-5 mg kg-‘) 
and the minimum dose required for complete clear- 
ance of worms calculated as 18 mg kg-’ (whereas we 
were unable to demonstrate total loss of worms with 
doses less than 25 mg kg-‘). 
This marked difference in sensitivity to ivermectin 
between hookworm genera has potential significance 
for the epidemiology of human hookworm infections 
in regions where A.duodenak and N.americanus are 
sympatric and where ivermectin is being used for the 
control of filariasis. Indeed there is already evidence 
from such studies in Africa that hookworm infections, 
which are predominantly ~.~ericanus, are unaffected 
by ivermectin at the doses which are employed to treat 
communities with onchocerciasis (150 pg kg-‘, 
Whitworth et af., 1991) or loiasis (5-200 pg kg-‘, 
Richard-Lenoble ef al., 1988). 
To our knowledge there is no clear-cut data on the 
effectiveness of ivermectin in patients with A.duodenale 
but in a study of patients harhouring single or mixed 
species infections Naquira, Jimenez, Guerra, Bernal, 
Nalin, Neu & Aziz (1989) reported that doses ranging 
from 50 to 2 x 200 pg kg-’ did not significantly affect 
prevalence of either species. At the highest dose level 
tested the cure rate was higher in patients harbouring 
A.duodenafe alone compared with those harbouring 
N.americanus (67 and 38%, respectively), perhaps 
indicating differential sensitivity but the sample sizes 
were too small to establish this point. However, there 
is considerable vidence from studies in animals that 
A.caninum in dogs (Egerton et al., 1985) and 
A.tubaeformae in cats (Fukase, In, Chinone, Akihama 
& Itagaki, 1991) are readily affected by doses of 
ivermectin comparable to those which we employed. 
Wang, Huang, Zhang, Yen & Wen (1989) reported 
complete clearance of A.caninum from dogs after 
treatment with only 10 pg kg-’ body weight, a dose 
corresponding in our study to ED,, for A.cey~an~cum. 
In hamsters complete clearance of A.ceylanicum 
necessitated a minimum dose of 100 pg kg-‘. 
However, it is well established that the metabolic 
activity of small animals is higher than that of larger 
animals and there is a negative correlation between 
body size and ED,, as well as ED,,. Thus, the IO-fold 
difference in the results reported here and those of 
Wang et al. (1989) is consistent with this 
interpretation, but we can only speculate until 
comparative experiments employing both 
Ancylostoma species in dogs are completed. The 
canine system could also be used to examine 
A.duodenu~e which can be maintained in dogs (Leiby, 
El Naggar & Schad, 1987). 
We were concerned that the difference between 
species in sensitivity to ivermectin may be attributable 
to some artifactual consequence of the experimental 
system which we employed (see Behnke, 1990), since 
both species of hookworm used in this study were 
adapted to passage through hamsters and were not 
tested in their natural definitive hosts. However, our 
results with pyrantel were reassuring since we con- 
cluded that Axeylanicum was marginally, if at all, 
more sensitive to pyrantel than N.americanus, and this 
is consistent with the reported comparable efficacy of 
pyrantel against both human hookworms (Ghadirian 
& Sanati, 1972; Rossignol, 1990). The standard 
treatment for humans is 10 mg kg-’ of pyrantel base 
for 3 days (Migasena & Gilles, 1991) which, taking 
relative body size into consideration, is also close to 
our values for over 90% efficacy in hamsters. Fur- 
thermore, our ED,, value for N.americunus (5-25 mg 
kg-’ was similar to that of 23.3 mg kg-’ given by 
Rajasekariah et al. (1989). 
However, the most interesting conclusion from this 
study is that N.americanus is extremely resistant to 
ivermectin, more so than Heligmosomoides polygyrus 
which is reputed for its insensitivity to this anthel- 
mintic (Wahid et al. 1989). The intriguing question 
which follows is why 2 organisms, representing 2 
genera closely related to each other, should show such 
marked disparity in sensitivity to ivermectin, despite 
comparable sensitivities to other commonly employed 
anthelmintics. It may also be pertinent that hook- 
worms of the genera Bunostomum and Gaigeria (see 
Yazwinski, 1988; Benz, Roncalli & Gross, 1989) which 
are more closely related to Necator than Ancylostoma 
are sensitive to ivermectin at doses of < 200 pg kg-‘. 
One possibility may be that in viuo, subcutaneously 
injected ivermectin has less access to N.amer~ca~us 
than to worms of other hookworm genera and in this 
context A.duodenale generally penetrate deeper into 
the gut mucosa than N.americanus (see Bonne, 1942; 
Zimmerman, 1946). Furthermore, A.duodenaIe is 
known to cause more profound blood loss than 
N.americanus in humans (Roche & Layrisse, 1966) but 
in our system A.ceylanicum is comparably the more 
Ivermectin and pyrantel sensitivity 951 
pathogenic (Behnke, 1991). However, we feel that this 
is an unlikely explanation for the relative insensitivity 
of N.americanus to ivermectin because other parasites 
such as Ascaris lumbricoides are extremely sensitive to 
ivermectin in orally treated patients whereas 
N.americanus is not. Furthermore, Uncinaria 
stenocephala and A.braziliense (see Egerton et al., 
1985; Henriques, Martin & Sievers, 1985; Campbell, 
1989) which cause only minimal blood loss and are 
regarded as mucosal surface browsers, are sensitive to 
subcutaneously administered ivermectin at doses of < 
50 pg kg-‘. 
Although it was originally widely believed that the 
principal target of ivermectin was GABA mediated 
transmission of signals to longitudinal muscles 
(Campbell, 1985) the exact mode of action is now 
disputed. The physiological effect of ivermectin is an 
increase in permeability of cell membranes to chloride 
ions (Turner & Schaeffer, 1989) and it has recently 
been proposed that a novel Cl - channel may be the 
receptor (reviewed Geary, Klein, Vanover, Bowman & 
Thompson, 1992). In Caenorhabditis elegans iver- 
mectin mediates its effect by binding to a specific high 
affinity binding site. The differential sensitivity 
observed in our experiments may thus result from 
some fundamental difference in the binding sites or 
chloride channels between worms from the genera 
Ancylostoma and Necator; but the differential sus- 
ceptibility of dogs to ivermectin has been clearly 
demonstrated not to be a result of chloride channel 
binding (Schaeffer, Rohrer, Cully & Arena, 1992) and 
hence there may be other explanations. Since there is 
evidence that ivermectin passes through the nematode 
cuticle (Ho, Geary, Barsuhn, Sims & Thompson, 
1992), our observations may suggest fundamental 
differences in the organization of the cuticle, perhaps 
at the molecular level. Alternatively differences be- 
tween the genera in permeability to ivermectin at the 
gut level following oral ingestion by the parasites or 
through cuticular pores associated with excretory 
activity or sensory structures such as cuticular papil- 
lae, amphids and phasmids may result in less 
ivermectin having access to relevant nerve junctions in 
worms of the genus Necator compared with Ancylo- 
stoma. Pharmacokinetic differences between the 
genera may be responsible for different concentrations 
of ivermectin reaching target sites. Such differences 
have been proposed to account for resistance of insects 
to commercial insecticides (Ahn, Funabi & 
Motoyama, 1992). One way to establish whether 
ivermectin has comparable or differential access to the 
nervous systems of Ancylostoma and Necator would 
be to employ fluorescent labelled ivermectin to 
quantify drug concentrations at nerve junctions 
following uniform exposure in vitro and/or in vivo 
(Martin, Kusel, Robertson, Minta & Haugland, 
1992), an approach which we are currently 
investigating. 
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